For a Limited Time: Get 3 Years of Access at the Price of 1
Here is the latest financial fact sheet of VALIANT LABORATORIES LTD.. For more details, see the VALIANT LABORATORIES LTD. quarterly results and VALIANT LABORATORIES LTD. share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -1.5 |
No. of shares | m | 43.45 |
1 Week | % | -6.9 |
1 Month | % | -12.9 |
1 Year | % | - |
52 week H/L | Rs | 227.0/140.0 |
No. of Mths Year Ending |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
VALIANT LABORATORIES LTD. EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | ||||
Low | Rs | NA | NA | ||||
Sales per share (Unadj.) | Rs | 179.1 | 102.6 | ||||
Earnings per share (Unadj.) | Rs | 16.9 | 8.9 | ||||
Diluted earnings per share | Rs | 6.3 | 6.7 | ||||
Cash flow per share (Unadj.) | Rs | 18.4 | 9.4 | ||||
Dividends per share (Unadj.) | Rs | 0 | 0 | ||||
Adj. dividends per share | Rs | 0.00 | 0.00 | ||||
Avg Dividend yield | % | 0 | 0 | ||||
Book value per share (Unadj.) | Rs | 43.9 | 30.9 | ||||
Adj. book value per share | Rs | 16.4 | 23.1 | ||||
Shares outstanding (eoy) | m | 16.28 | 32.56 | ||||
Price / Sales ratio | x | 0 | 0 | ||||
Avg P/E ratio | x | 0 | 0 | ||||
P/CF ratio (eoy) | x | 0 | 0 | ||||
Price / Book Value ratio | x | 0 | 0 | ||||
Dividend payout | % | 0 | 0 | ||||
Avg Mkt Cap | Rs m | 0 | 0 | ||||
Total wages/salary | Rs m | 31 | 46 |
VALIANT LABORATORIES LTD. INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 2,915 | 3,339 | ||||
Other income | Rs m | 19 | 49 | ||||
Total revenues | Rs m | 2,935 | 3,388 | ||||
Gross profit | Rs m | 423 | 351 | ||||
Depreciation | Rs m | 25 | 16 | ||||
Interest | Rs m | 1 | 3 | ||||
Profit before tax | Rs m | 417 | 381 | ||||
Minority Interest | Rs m | 0 | 0 | ||||
Prior Period Items | Rs m | 0 | 0 | ||||
Extraordinary Inc (Exp) | Rs m | 0 | 0 | ||||
Tax | Rs m | 142 | 91 | ||||
Profit after tax | Rs m | 275 | 290 | ||||
Gross profit margin | % | 14.5 | 10.5 | ||||
Effective tax rate | % | 34.1 | 24.0 | ||||
Net profit margin | % | 9.4 | 8.7 |
VALIANT LABORATORIES LTD. BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,568 | 1,506 | ||||
Current liabilities | Rs m | 494 | 507 | ||||
Net working cap to sales | % | 36.8 | 29.9 | ||||
Current ratio | x | 3.2 | 3.0 | ||||
Inventory Days | Days | 2 | 52 | ||||
Debtors Days | Days | 139 | 97 | ||||
Net fixed assets | Rs m | 250 | 624 | ||||
Share capital | Rs m | 163 | 326 | ||||
"Free" reserves | Rs m | 552 | 679 | ||||
Net worth | Rs m | 715 | 1,005 | ||||
Long term debt | Rs m | 594 | 594 | ||||
Total assets | Rs m | 1,818 | 2,130 | ||||
Interest coverage | x | 572.3 | 151.1 | ||||
Debt to equity ratio | x | 0.8 | 0.6 | ||||
Sales to assets ratio | x | 1.6 | 1.6 | ||||
Return on assets | % | 15.2 | 13.7 | ||||
Return on equity | % | 38.5 | 28.9 | ||||
Return on capital | % | 31.9 | 24.0 | ||||
Exports to sales | % | 0 | 0 | ||||
Imports to sales | % | 0 | 0 | ||||
Exports (fob) | Rs m | 0 | 0 | ||||
Imports (cif) | Rs m | 0 | 0 | ||||
Fx inflow | Rs m | 0 | 0 | ||||
Fx outflow | Rs m | 0 | 0 | ||||
Net fx | Rs m | 0 | 0 |
VALIANT LABORATORIES LTD. CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 23 | 561 | ||||
From Investments | Rs m | -122 | -552 | ||||
From Financial Activity | Rs m | 62 | -9 | ||||
Net Cashflow | Rs m | -38 | -1 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Velji Gogri | COMP SEC: Saloni Mehta | YEAR OF INC: 2021 | BSE CODE: 543998 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare VALIANT LABORATORIES LTD. With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
On Friday, Indian share markets traded on a positive note throughout the trading session and ended higher.